Zhitong Finance App News, Shu Taishen (300204.SZ) announced that on January 10, 2024, the company and sponsor Guojin Securities Co., Ltd. submitted the “Application of Shu Taishen (Beijing) Biopharmaceutical Co., Ltd. to withdraw the 2022 application documents for issuing shares to specific targets and listing on GEM” and “Guojin Securities Co., Ltd.'s application to withdraw the application documents for the 2022 issuance of shares to specific targets and listing on GEM” to the Shenzhen Stock Exchange. The Shenzhen Stock Exchange decided to terminate the review of the company's application to issue shares to specific targets.
舒泰神(300204.SZ)：深交所终止审核公司定增股票事项
Shu Taishen (300204.SZ): The Shenzhen Stock Exchange terminated the review of the company's fixed stock increase
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.